G&W Laboratories Inc.
Industry
- Pharmaceuticals
- OTC, Consumer
Latest on G&W Laboratories Inc.
Global investment firm The Carlyle Group is acquiring 20% in the Piramal group's pharma business for around $490m, setting the stage for the Indian group to pursue an ambitious growth strategy includi
Promethera Links With Hao Tian On JV For NASH, ACLF, Hepatic Cancer Promethera Biosciences and Hong Kong-based Hao Tian Development Group Ltd. said on 16 July they had entered into an agreement to f
Global investment firm The Carlyle Group is acquiring 20% in the Piramal group’s pharma business for around $490m, setting the stage for the Indian group to pursue an ambitious growth strategy includi
The US FDA will calculate the newest generic drug user fee based on ANDA ownership with some 1,900 applications classified as unclaimed. Applications with missing ownership data account for about 20%